158 related articles for article (PubMed ID: 36890610)
21. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
22. Genomic organization and expression of a human gene for Myc-associated zinc finger protein (MAZ).
Song J; Murakami H; Tsutsui H; Tang X; Matsumura M; Itakura K; Kanazawa I; Sun K; Yokoyama KK
J Biol Chem; 1998 Aug; 273(32):20603-14. PubMed ID: 9685418
[TBL] [Abstract][Full Text] [Related]
23. PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.
Skalsky YM; Ajuh PM; Parker C; Lamond AI; Goodwin G; Cooper CS
Oncogene; 2001 Jan; 20(2):178-87. PubMed ID: 11313942
[TBL] [Abstract][Full Text] [Related]
24. MGA, L3MBTL2 and E2F6 determine genomic binding of the non-canonical Polycomb repressive complex PRC1.6.
Stielow B; Finkernagel F; Stiewe T; Nist A; Suske G
PLoS Genet; 2018 Jan; 14(1):e1007193. PubMed ID: 29381691
[TBL] [Abstract][Full Text] [Related]
25. Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma.
Douglas ML; Richardson MM; Nicol DL
Cancer; 2004 May; 100(10):2118-24. PubMed ID: 15139053
[TBL] [Abstract][Full Text] [Related]
26. PCGF6 controls neuroectoderm specification of human pluripotent stem cells by activating SOX2 expression.
Lan X; Ding S; Zhang T; Yi Y; Li C; Jin W; Chen J; Liang K; Wang H; Jiang W
Nat Commun; 2022 Aug; 13(1):4601. PubMed ID: 35933409
[TBL] [Abstract][Full Text] [Related]
27. PCGF6 regulates stem cell pluripotency as a transcription activator via super-enhancer dependent chromatin interactions.
Huang X; Wei C; Li F; Jia L; Zeng P; Li J; Tan J; Sun T; Jiang S; Wang J; Tang X; Zhao Q; Liu B; Rong L; Li C; Ding J
Protein Cell; 2019 Oct; 10(10):709-725. PubMed ID: 31041782
[TBL] [Abstract][Full Text] [Related]
28. Myc-Associated Zinc Finger Protein Promotes Metastasis of Papillary Thyroid Cancer.
Zheng C; Wu H; Zhang S; Tian R; Long H; Zhang H; Guo X; Li D; Tan S; Zhu X
Front Biosci (Landmark Ed); 2023 Aug; 28(8):162. PubMed ID: 37664917
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation by zinc-finger proteins Sp1 and MAZ involves interactions with the same cis-elements.
Song J; Ugai H; Nakata-Tsutsui H; Kishikawa S; Suzuki E; Murata T; Yokoyama KK
Int J Mol Med; 2003 May; 11(5):547-53. PubMed ID: 12684688
[TBL] [Abstract][Full Text] [Related]
30. Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis.
Tanaskovic N; Dalsass M; Filipuzzi M; Ceccotti G; Verrecchia A; Nicoli P; Doni M; Olivero D; Pasini D; Koseki H; Sabò A; Bisso A; Amati B
Life Sci Alliance; 2022 Aug; 5(8):. PubMed ID: 35422437
[TBL] [Abstract][Full Text] [Related]
31. Interaction of Myc-associated zinc finger protein with DCC, the product of a tumor-suppressor gene, during the neural differentiation of P19 EC cells.
Ugai H; Li HO; Komatsu M; Tsutsui H; Song J; Shiga T; Fearon E; Murata T; Yokoyama KK
Biochem Biophys Res Commun; 2001 Sep; 286(5):1087-97. PubMed ID: 11527412
[TBL] [Abstract][Full Text] [Related]
32. G-quadruplexes promote the motility in MAZ phase-separated condensates to activate CCND1 expression and contribute to hepatocarcinogenesis.
Wang W; Li D; Xu Q; Cheng J; Yu Z; Li G; Qiao S; Pan J; Wang H; Shi J; Zheng T; Sui G
Nat Commun; 2024 Feb; 15(1):1045. PubMed ID: 38316778
[TBL] [Abstract][Full Text] [Related]
33. Roles of Myc-associated zinc finger protein in malignant tumors.
Zheng C; Wu H; Jin S; Li D; Tan S; Zhu X
Asia Pac J Clin Oncol; 2022 Dec; 18(6):506-514. PubMed ID: 35098656
[TBL] [Abstract][Full Text] [Related]
34. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination.
Bossone SA; Asselin C; Patel AJ; Marcu KB
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7452-6. PubMed ID: 1502157
[TBL] [Abstract][Full Text] [Related]
35. A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data.
Zhao H; Leppert JT; Peehl DM
PLoS One; 2016; 11(1):e0146505. PubMed ID: 26814892
[TBL] [Abstract][Full Text] [Related]
36. miR-34c regulates the permeability of blood-tumor barrier via MAZ-mediated expression changes of ZO-1, occludin, and claudin-5.
Zhao L; Wang P; Liu Y; Ma J; Xue Y
J Cell Physiol; 2015 Mar; 230(3):716-31. PubMed ID: 25201524
[TBL] [Abstract][Full Text] [Related]
37. 16p11.2 transcription factor
Haller M; Au J; O'Neill M; Lamb DJ
Proc Natl Acad Sci U S A; 2018 Feb; 115(8):E1849-E1858. PubMed ID: 29432158
[TBL] [Abstract][Full Text] [Related]
38. FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma.
Tsimafeyeu I; Khasanova A; Stepanova E; Gordiev M; Khochenkov D; Naumova A; Varlamov I; Snegovoy A; Demidov L
Clin Transl Oncol; 2017 Feb; 19(2):265-268. PubMed ID: 27379982
[TBL] [Abstract][Full Text] [Related]
39. Identification of the transcription factor MAZ as a regulator of erythropoiesis.
Deen D; Butter F; Daniels DE; Ferrer-Vicens I; Ferguson DCJ; Holland ML; Samara V; Sloane-Stanley JA; Ayyub H; Mann M; Frayne J; Garrick D; Vernimmen D
Blood Adv; 2021 Aug; 5(15):3002-3015. PubMed ID: 34351390
[TBL] [Abstract][Full Text] [Related]
40. Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
Wagener N; Edelmann D; Benner A; Zigeuner R; Borgmann H; Wolff I; Krabbe LM; Musquera M; Dell'Oglio P; Capitanio U; Klatte T; Cindolo L; May M; Brookman-May SD;
PLoS One; 2017; 12(9):e0184173. PubMed ID: 28934212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
